FDA Issues Consumer Warning to Stop All THC Vaping Product Use Due to Lung Illness Concerns

The FDA released their statement against THC vaping on October 4^th. No regulations have been established for CBD still, despite requests from Congress and advocacy groups.

Multiple reports of lung illness related to vaping THC have come out in the last year, and the government has continually warned of this issue. The CDC has updated the public on the ongoing research they’ve had, discovering that over half of the reports have been connected to THC from the black market.

The Food and Drug Administration recently released a statement, encouraging consumers to “stop using THC vaping products amid ongoing investigation into lung illnesses.” The statement, which was released on October 4^th, states that they’ve been “working tirelessly” with the CDC to learn more about these “distressing incidents.” Now, the authority is being direct, stating that consumers should not use any THC vaping products.

Should consumers continue to use THC vaping products, they are advised not to “modify or add any substances such as THC or other oils to products purchased in stores and should not purchase any vaping products, including those containing THC, off the street or from other illicit channels.” Consumers that continue to use legal ways to acquire their THC products, or that use other vaping products, are urged to “monitor for symptoms and promptly seek medical attention if you have concerns.”

The FDA is also asking that the public submit any health or product issues with any vaping activities, using the Safety Reporting Portal online. It also reiterates a previous statement, adding that pregnant women and all youth should not be using any vaping product at all.

Much of the reason for this statement release is to follow direction that the FDA submitted a few weeks ago, since the circumstances around the vaping illnesses are still evolving.

Even though the statement touches on the necessity for the public to stop vaping and to be aware of any possibility of lung disease, there has yet to be any further regulations established for the CBD industry. Congress and multiple advocacy groups have urged the FDA to establish regulations that could help the public avoid the black market all together, but those requests appear to not be a priority presently.